Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 127

1.

Imaging Biomarkers of Alzheimer Disease in Multiple Sclerosis.

Zeydan B, Lowe VJ, Reichard RR, Przybelski SA, Lesnick TG, Schwarz CG, Senjem ML, Gunter JL, Parisi JE, Machulda MM, Vemuri P, Mielke MM, Knopman DS, Petersen RC, Jack CR Jr, Kantarci OH, Kantarci K.

Ann Neurol. 2020 Apr;87(4):556-567. doi: 10.1002/ana.25684. Epub 2020 Feb 8.

PMID:
31970802
2.

β-Amyloid PET and neuropathology in dementia with Lewy bodies.

Kantarci K, Lowe VJ, Chen Q, Przybelski SA, Lesnick TG, Schwarz CG, Senjem ML, Gunter JL, Jack CR Jr, Graff-Radford J, Jones DT, Knopman DS, Graff-Radford N, Ferman TJ, Parisi JE, Dickson DW, Petersen RC, Boeve BF, Murray ME.

Neurology. 2020 Jan 21;94(3):e282-e291. doi: 10.1212/WNL.0000000000008818. Epub 2019 Dec 20.

PMID:
31862783
3.

Association of Longitudinal β-Amyloid Accumulation Determined by Positron Emission Tomography With Clinical and Cognitive Decline in Adults With Probable Lewy Body Dementia.

Nedelska Z, Schwarz CG, Lesnick TG, Boeve BF, Przybelski SA, Lowe VJ, Kremers WK, Gunter JL, Senjem ML, Graff-Radford J, Ferman TJ, Fields JA, Knopman DS, Petersen RC, Jack CR Jr, Kantarci K.

JAMA Netw Open. 2019 Dec 2;2(12):e1916439. doi: 10.1001/jamanetworkopen.2019.16439.

4.

Linear vs volume measures of ventricle size: Relation to present and future gait and cognition.

Crook JE, Gunter JL, Ball CT, Jones DT, Graff-Radford J, Knopman DS, Boeve BF, Petersen RC, Jack CR, Graff-Radford NR.

Neurology. 2020 Feb 4;94(5):e549-e556. doi: 10.1212/WNL.0000000000008673. Epub 2019 Nov 20.

PMID:
31748251
5.

Cerebrospinal fluid dynamics disorders: Relationship to Alzheimer biomarkers and cognition.

Graff-Radford J, Gunter JL, Jones DT, Przybelski SA, Schwarz CG, Huston J 3rd, Lowe V, Elder BD, Machulda MM, Gunter NB, Petersen RC, Kantarci K, Vemuri P, Mielke MM, Knopman DS, Graff-Radford NR, Jack CR Jr.

Neurology. 2019 Dec 10;93(24):e2237-e2246. doi: 10.1212/WNL.0000000000008616. Epub 2019 Nov 12.

PMID:
31719134
6.

Identification of Anonymous MRI Research Participants with Face-Recognition Software.

Schwarz CG, Kremers WK, Therneau TM, Sharp RR, Gunter JL, Vemuri P, Arani A, Spychalla AJ, Kantarci K, Knopman DS, Petersen RC, Jack CR Jr.

N Engl J Med. 2019 Oct 24;381(17):1684-1686. doi: 10.1056/NEJMc1908881. No abstract available.

PMID:
31644852
7.

Cardiometabolic Health and Longitudinal Progression of White Matter Hyperintensity: The Mayo Clinic Study of Aging.

Scharf EL, Graff-Radford J, Przybelski SA, Lesnick TG, Mielke MM, Knopman DS, Preboske GM, Schwarz CG, Senjem ML, Gunter JL, Machulda M, Kantarci K, Petersen RC, Jack CR Jr, Vemuri P.

Stroke. 2019 Nov;50(11):3037-3044. doi: 10.1161/STROKEAHA.119.025822. Epub 2019 Sep 12.

PMID:
31510903
8.

The bivariate distribution of amyloid-β and tau: relationship with established neurocognitive clinical syndromes.

Jack CR, Wiste HJ, Botha H, Weigand SD, Therneau TM, Knopman DS, Graff-Radford J, Jones DT, Ferman TJ, Boeve BF, Kantarci K, Lowe VJ, Vemuri P, Mielke MM, Fields JA, Machulda MM, Schwarz CG, Senjem ML, Gunter JL, Petersen RC.

Brain. 2019 Oct 1;142(10):3230-3242. doi: 10.1093/brain/awz268.

9.

Frontal lobe 1H MR spectroscopy in asymptomatic and symptomatic MAPT mutation carriers.

Chen Q, Boeve BF, Tosakulwong N, Lesnick T, Brushaber D, Dheel C, Fields J, Forsberg L, Gavrilova R, Gearhart D, Haley D, Gunter JL, Graff-Radford J, Jones D, Knopman D, Graff-Radford N, Kraft R, Lapid M, Rademakers R, Syrjanen J, Wszolek ZK, Rosen H, Boxer AL, Kantarci K.

Neurology. 2019 Aug 20;93(8):e758-e765. doi: 10.1212/WNL.0000000000007961. Epub 2019 Jul 17.

PMID:
31315971
10.

Prevalence of Biologically vs Clinically Defined Alzheimer Spectrum Entities Using the National Institute on Aging-Alzheimer's Association Research Framework.

Jack CR Jr, Therneau TM, Weigand SD, Wiste HJ, Knopman DS, Vemuri P, Lowe VJ, Mielke MM, Roberts RO, Machulda MM, Graff-Radford J, Jones DT, Schwarz CG, Gunter JL, Senjem ML, Rocca WA, Petersen RC.

JAMA Neurol. 2019 Jul 15. doi: 10.1001/jamaneurol.2019.1971. [Epub ahead of print]

11.

Associations of Amyloid, Tau, and Neurodegeneration Biomarker Profiles With Rates of Memory Decline Among Individuals Without Dementia.

Jack CR Jr, Wiste HJ, Therneau TM, Weigand SD, Knopman DS, Mielke MM, Lowe VJ, Vemuri P, Machulda MM, Schwarz CG, Gunter JL, Senjem ML, Graff-Radford J, Jones DT, Roberts RO, Rocca WA, Petersen RC.

JAMA. 2019 Jun 18;321(23):2316-2325. doi: 10.1001/jama.2019.7437.

12.

White matter hyperintensities: relationship to amyloid and tau burden.

Graff-Radford J, Arenaza-Urquijo EM, Knopman DS, Schwarz CG, Brown RD, Rabinstein AA, Gunter JL, Senjem ML, Przybelski SA, Lesnick T, Ward C, Mielke MM, Lowe VJ, Petersen RC, Kremers WK, Kantarci K, Jack CR, Vemuri P.

Brain. 2019 Aug 1;142(8):2483-2491. doi: 10.1093/brain/awz162.

PMID:
31199475
13.

Progressive agrammatic aphasia without apraxia of speech as a distinct syndrome.

Tetzloff KA, Duffy JR, Clark HM, Utianski RL, Strand EA, Machulda MM, Botha H, Martin PR, Schwarz CG, Senjem ML, Reid RI, Gunter JL, Spychalla AJ, Knopman DS, Petersen RC, Jack CR, Lowe VJ, Josephs KA, Whitwell JL.

Brain. 2019 Aug 1;142(8):2466-2482. doi: 10.1093/brain/awz157.

PMID:
31199471
14.

Brain MR Spectroscopy Changes Precede Frontotemporal Lobar Degeneration Phenoconversion in Mapt Mutation Carriers.

Chen Q, Boeve BF, Tosakulwong N, Lesnick T, Brushaber D, Dheel C, Fields J, Forsberg L, Gavrilova R, Gearhart D, Haley D, Gunter JL, Graff-Radford J, Jones D, Knopman D, Graff-Radford N, Kraft R, Lapid M, Rademakers R, Wszolek ZK, Rosen H, Boxer AL, Kantarci K.

J Neuroimaging. 2019 Sep;29(5):624-629. doi: 10.1111/jon.12642. Epub 2019 Jun 7.

15.

Investigation of white matter PiB uptake as a marker of white matter integrity.

Zeydan B, Schwarz CG, Lowe VJ, Reid RI, Przybelski SA, Lesnick TG, Kremers WK, Senjem ML, Gunter JL, Min HK, Vemuri P, Knopman DS, Petersen RC, Jack CR Jr, Kantarci OH, Kantarci K.

Ann Clin Transl Neurol. 2019 Mar 3;6(4):678-688. doi: 10.1002/acn3.741. eCollection 2019 Apr.

16.

Entorhinal cortex tau, amyloid-β, cortical thickness and memory performance in non-demented subjects.

Knopman DS, Lundt ES, Therneau TM, Vemuri P, Lowe VJ, Kantarci K, Gunter JL, Senjem ML, Mielke MM, Machulda MM, Boeve BF, Jones DT, Graff-Radford J, Albertson SM, Schwarz CG, Petersen RC, Jack CR.

Brain. 2019 Apr 1;142(4):1148-1160. doi: 10.1093/brain/awz025.

17.

Neural correlates of domain-specific cognitive decline: The ARIC-NCS Study.

Schneider ALC, Senjem ML, Wu A, Gross A, Knopman DS, Gunter JL, Schwarz CG, Mosley TH, Gottesman RF, Sharrett AR, Jack CR Jr.

Neurology. 2019 Mar 5;92(10):e1051-e1063. doi: 10.1212/WNL.0000000000007042. Epub 2019 Feb 6.

18.

Recommendations towards standards for quantitative MRI (qMRI) and outstanding needs.

Keenan KE, Biller JR, Delfino JG, Boss MA, Does MD, Evelhoch JL, Griswold MA, Gunter JL, Hinks RS, Hoffman SW, Kim G, Lattanzi R, Li X, Marinelli L, Metzger GJ, Mukherjee P, Nordstrom RJ, Peskin AP, Perez E, Russek SE, Sahiner B, Serkova N, Shukla-Dave A, Steckner M, Stupic KF, Wilmes LJ, Wu HH, Zhang H, Jackson EF, Sullivan DC.

J Magn Reson Imaging. 2019 Jun;49(7):e26-e39. doi: 10.1002/jmri.26598. Epub 2019 Jan 24.

PMID:
30680836
19.

Cerebral microbleeds: Prevalence and relationship to amyloid burden.

Graff-Radford J, Botha H, Rabinstein AA, Gunter JL, Przybelski SA, Lesnick T, Huston J 3rd, Flemming KD, Preboske GM, Senjem ML, Brown RD Jr, Mielke MM, Roberts RO, Lowe VJ, Knopman DS, Petersen RC, Kremers W, Vemuri P, Jack CR Jr, Kantarci K.

Neurology. 2019 Jan 15;92(3):e253-e262. doi: 10.1212/WNL.0000000000006780. Epub 2018 Dec 19.

20.

Automated detection of imaging features of disproportionately enlarged subarachnoid space hydrocephalus using machine learning methods.

Gunter NB, Schwarz CG, Graff-Radford J, Gunter JL, Jones DT, Graff-Radford NR, Petersen RC, Knopman DS, Jack CR Jr.

Neuroimage Clin. 2019;21:101605. doi: 10.1016/j.nicl.2018.11.015. Epub 2018 Nov 19.

21.

A Comparison of Partial Volume Correction Techniques for Measuring Change in Serial Amyloid PET SUVR.

Schwarz CG, Gunter JL, Lowe VJ, Weigand S, Vemuri P, Senjem ML, Petersen RC, Knopman DS, Jack CR.

J Alzheimers Dis. 2019;67(1):181-195. doi: 10.3233/JAD-180749.

22.

Association of Bilateral Salpingo-Oophorectomy Before Menopause Onset With Medial Temporal Lobe Neurodegeneration.

Zeydan B, Tosakulwong N, Schwarz CG, Senjem ML, Gunter JL, Reid RI, Gazzuola Rocca L, Lesnick TG, Smith CY, Bailey KR, Lowe VJ, Roberts RO, Jack CR Jr, Petersen RC, Miller VM, Mielke MM, Rocca WA, Kantarci K.

JAMA Neurol. 2019 Jan 1;76(1):95-100. doi: 10.1001/jamaneurol.2018.3057.

23.

Development of a cerebrovascular magnetic resonance imaging biomarker for cognitive aging.

Vemuri P, Lesnick TG, Przybelski SA, Graff-Radford J, Reid RI, Lowe VJ, Zuk SM, Senjem ML, Schwarz CG, Gunter JL, Kantarci K, Machulda MM, Mielke MM, Petersen RC, Knopman DS, Jack CR Jr.

Ann Neurol. 2018 Nov;84(5):705-716. doi: 10.1002/ana.25346. Epub 2018 Oct 25.

24.

Considerations for Performing Level-2 Centiloid Transformations for Amyloid PET SUVR values.

Schwarz CG, Tosakulwong N, Senjem ML, Gunter JL, Therneau TM, Vemuri P, Lowe VJ, Jack CR Jr.

Sci Rep. 2018 May 9;8(1):7421. doi: 10.1038/s41598-018-25459-9.

25.

Brain structure and cognition 3 years after the end of an early menopausal hormone therapy trial.

Kantarci K, Tosakulwong N, Lesnick TG, Zuk SM, Lowe VJ, Fields JA, Gunter JL, Senjem ML, Settell ML, Gleason CE, Shuster LT, Bailey KR, Dowling NM, Asthana S, Jack CR Jr, Rocca WA, Miller VM.

Neurology. 2018 Apr 17;90(16):e1404-e1412. doi: 10.1212/WNL.0000000000005325. Epub 2018 Mar 21.

26.

Longitudinal tau PET in ageing and Alzheimer's disease.

Jack CR Jr, Wiste HJ, Schwarz CG, Lowe VJ, Senjem ML, Vemuri P, Weigand SD, Therneau TM, Knopman DS, Gunter JL, Jones DT, Graff-Radford J, Kantarci K, Roberts RO, Mielke MM, Machulda MM, Petersen RC.

Brain. 2018 May 1;141(5):1517-1528. doi: 10.1093/brain/awy059.

27.

Joint associations of β-amyloidosis and cortical thickness with cognition.

Knopman DS, Lundt ES, Therneau TM, Vemuri P, Lowe VJ, Kantarci K, Gunter JL, Senjem ML, Mielke MM, Machulda MM, Roberts RO, Boeve BF, Jones DT, Petersen RC, Jack CR Jr.

Neurobiol Aging. 2018 May;65:121-131. doi: 10.1016/j.neurobiolaging.2018.01.017. Epub 2018 Feb 2.

28.

Tau, amyloid, and cascading network failure across the Alzheimer's disease spectrum.

Jones DT, Graff-Radford J, Lowe VJ, Wiste HJ, Gunter JL, Senjem ML, Botha H, Kantarci K, Boeve BF, Knopman DS, Petersen RC, Jack CR Jr.

Cortex. 2017 Dec;97:143-159. doi: 10.1016/j.cortex.2017.09.018. Epub 2017 Oct 3.

29.

Quantitative magnetic resonance imaging phantoms: A review and the need for a system phantom.

Keenan KE, Ainslie M, Barker AJ, Boss MA, Cecil KM, Charles C, Chenevert TL, Clarke L, Evelhoch JL, Finn P, Gembris D, Gunter JL, Hill DLG, Jack CR Jr, Jackson EF, Liu G, Russek SE, Sharma SD, Steckner M, Stupic KF, Trzasko JD, Yuan C, Zheng J.

Magn Reson Med. 2018 Jan;79(1):48-61. doi: 10.1002/mrm.26982. Epub 2017 Oct 30. Review.

30.

Comparison of [18F]Flutemetamol and [11C]Pittsburgh Compound-B in cognitively normal young, cognitively normal elderly, and Alzheimer's disease dementia individuals.

Lowe VJ, Lundt E, Knopman D, Senjem ML, Gunter JL, Schwarz CG, Kemp BJ, Jack CR Jr, Petersen RC.

Neuroimage Clin. 2017 Aug 14;16:295-302. doi: 10.1016/j.nicl.2017.08.011. eCollection 2017.

31.

White-matter integrity on DTI and the pathologic staging of Alzheimer's disease.

Kantarci K, Murray ME, Schwarz CG, Reid RI, Przybelski SA, Lesnick T, Zuk SM, Raman MR, Senjem ML, Gunter JL, Boeve BF, Knopman DS, Parisi JE, Petersen RC, Jack CR Jr, Dickson DW.

Neurobiol Aging. 2017 Aug;56:172-179. doi: 10.1016/j.neurobiolaging.2017.04.024. Epub 2017 May 4.

32.

Pittsburgh compound-B PET white matter imaging and cognitive function in late multiple sclerosis.

Zeydan B, Lowe VJ, Schwarz CG, Przybelski SA, Tosakulwong N, Zuk SM, Senjem ML, Gunter JL, Roberts RO, Mielke MM, Benarroch EE, Rodriguez M, Machulda MM, Lesnick TG, Knopman DS, Petersen RC, Jack CR Jr, Kantarci K, Kantarci OH.

Mult Scler. 2018 May;24(6):739-749. doi: 10.1177/1352458517707346. Epub 2017 May 5.

33.

Age-specific and sex-specific prevalence of cerebral β-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50-95 years: a cross-sectional study.

Jack CR Jr, Wiste HJ, Weigand SD, Therneau TM, Knopman DS, Lowe V, Vemuri P, Mielke MM, Roberts RO, Machulda MM, Senjem ML, Gunter JL, Rocca WA, Petersen RC.

Lancet Neurol. 2017 Jun;16(6):435-444. doi: 10.1016/S1474-4422(17)30077-7. Epub 2017 Apr 26.

34.

Contributions of imprecision in PET-MRI rigid registration to imprecision in amyloid PET SUVR measurements.

Schwarz CG, Jones DT, Gunter JL, Lowe VJ, Vemuri P, Senjem ML, Petersen RC, Knopman DS, Jack CR Jr; Alzheimer's Disease Neuroimaging Initiative.

Hum Brain Mapp. 2017 Jul;38(7):3323-3336. doi: 10.1002/hbm.23622. Epub 2017 Apr 22.

35.

Aortic hemodynamics and white matter hyperintensities in normotensive postmenopausal women.

Barnes JN, Harvey RE, Zuk SM, Lundt ES, Lesnick TG, Gunter JL, Senjem ML, Shuster LT, Miller VM, Jack CR Jr, Joyner MJ, Kantarci K.

J Neurol. 2017 May;264(5):938-945. doi: 10.1007/s00415-017-8476-1. Epub 2017 Apr 7.

36.

A large-scale comparison of cortical thickness and volume methods for measuring Alzheimer's disease severity.

Schwarz CG, Gunter JL, Wiste HJ, Przybelski SA, Weigand SD, Ward CP, Senjem ML, Vemuri P, Murray ME, Dickson DW, Parisi JE, Kantarci K, Weiner MW, Petersen RC, Jack CR Jr; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage Clin. 2016 May 30;11:802-812. doi: 10.1016/j.nicl.2016.05.017. eCollection 2016.

37.

Image-based gradient non-linearity characterization to determine higher-order spherical harmonic coefficients for improved spatial position accuracy in magnetic resonance imaging.

Weavers PT, Tao S, Trzasko JD, Shu Y, Tryggestad EJ, Gunter JL, McGee KP, Litwiller DV, Hwang KP, Bernstein MA.

Magn Reson Imaging. 2017 May;38:54-62. doi: 10.1016/j.mri.2016.12.020. Epub 2016 Dec 27.

38.

Gradient nonlinearity calibration and correction for a compact, asymmetric magnetic resonance imaging gradient system.

Tao S, Trzasko JD, Gunter JL, Weavers PT, Shu Y, Huston J, Lee SK, Tan ET, Bernstein MA.

Phys Med Biol. 2017 Jan 21;62(2):N18-N31. doi: 10.1088/1361-6560/aa524f. Epub 2016 Dec 29.

39.

AV-1451 tau and β-amyloid positron emission tomography imaging in dementia with Lewy bodies.

Kantarci K, Lowe VJ, Boeve BF, Senjem ML, Tosakulwong N, Lesnick TG, Spychalla AJ, Gunter JL, Fields JA, Graff-Radford J, Ferman TJ, Jones DT, Murray ME, Knopman DS, Jack CR Jr, Petersen RC.

Ann Neurol. 2017 Jan;81(1):58-67. doi: 10.1002/ana.24825. Epub 2016 Dec 19.

40.

Defining imaging biomarker cut points for brain aging and Alzheimer's disease.

Jack CR Jr, Wiste HJ, Weigand SD, Therneau TM, Lowe VJ, Knopman DS, Gunter JL, Senjem ML, Jones DT, Kantarci K, Machulda MM, Mielke MM, Roberts RO, Vemuri P, Reyes DA, Petersen RC.

Alzheimers Dement. 2017 Mar;13(3):205-216. doi: 10.1016/j.jalz.2016.08.005. Epub 2016 Sep 30.

41.

Tracking the development of agrammatic aphasia: A tensor-based morphometry study.

Whitwell JL, Duffy JR, Machulda MM, Clark HM, Strand EA, Senjem ML, Gunter JL, Spychalla AJ, Petersen RC, Jack CR Jr, Josephs KA.

Cortex. 2017 May;90:138-148. doi: 10.1016/j.cortex.2016.09.017. Epub 2016 Sep 30.

42.

Optimizing PiB-PET SUVR change-over-time measurement by a large-scale analysis of longitudinal reliability, plausibility, separability, and correlation with MMSE.

Schwarz CG, Senjem ML, Gunter JL, Tosakulwong N, Weigand SD, Kemp BJ, Spychalla AJ, Vemuri P, Petersen RC, Lowe VJ, Jack CR Jr.

Neuroimage. 2017 Jan 1;144(Pt A):113-127. doi: 10.1016/j.neuroimage.2016.08.056. Epub 2016 Aug 27.

43.

Brain structural changes following adaptive cognitive training assessed by Tensor-Based Morphometry (TBM).

Colom R, Hua X, Martínez K, Burgaleta M, Román FJ, Gunter JL, Carmona S, Jaeggi SM, Thompson PM.

Neuropsychologia. 2016 Oct;91:77-85. doi: 10.1016/j.neuropsychologia.2016.07.034. Epub 2016 Jul 28.

44.

Effects of hormone therapy on brain structure: A randomized controlled trial.

Kantarci K, Tosakulwong N, Lesnick TG, Zuk SM, Gunter JL, Gleason CE, Wharton W, Dowling NM, Vemuri P, Senjem ML, Shuster LT, Bailey KR, Rocca WA, Jack CR Jr, Asthana S, Miller VM.

Neurology. 2016 Aug 30;87(9):887-96. doi: 10.1212/WNL.0000000000002970. Epub 2016 Jul 29.

45.

Evolution of neurodegeneration-imaging biomarkers from clinically normal to dementia in the Alzheimer disease spectrum.

Knopman DS, Jack CR Jr, Lundt ES, Weigand SD, Vemuri P, Lowe VJ, Kantarci K, Gunter JL, Senjem ML, Mielke MM, Machulda MM, Roberts RO, Boeve BF, Jones DT, Petersen RC.

Neurobiol Aging. 2016 Oct;46:32-42. doi: 10.1016/j.neurobiolaging.2016.06.003. Epub 2016 Jun 16.

46.

Age and neurodegeneration imaging biomarkers in persons with Alzheimer disease dementia.

Knopman DS, Jack CR Jr, Wiste HJ, Weigand SD, Vemuri P, Lowe VJ, Kantarci K, Gunter JL, Senjem ML, Mielke MM, Machulda MM, Roberts RO, Boeve BF, Jones DT, Petersen RC.

Neurology. 2016 Aug 16;87(7):691-8. doi: 10.1212/WNL.0000000000002979. Epub 2016 Jul 15.

47.

Predicting Survival in Dementia With Lewy Bodies With Hippocampal Volumetry.

Graff-Radford J, Lesnick TG, Boeve BF, Przybelski SA, Jones DT, Senjem ML, Gunter JL, Ferman TJ, Knopman DS, Murray ME, Dickson DW, Sarro L, Jack CR Jr, Petersen RC, Kantarci K.

Mov Disord. 2016 Jul;31(7):989-94. doi: 10.1002/mds.26666. Epub 2016 May 23.

48.

Clinical and MRI models predicting amyloid deposition in progressive aphasia and apraxia of speech.

Whitwell JL, Weigand SD, Duffy JR, Strand EA, Machulda MM, Senjem ML, Gunter JL, Lowe VJ, Jack CR Jr, Josephs KA.

Neuroimage Clin. 2016 Jan 20;11:90-98. doi: 10.1016/j.nicl.2016.01.014. eCollection 2016.

49.

Effect of intellectual enrichment on AD biomarker trajectories: Longitudinal imaging study.

Vemuri P, Lesnick TG, Przybelski SA, Knopman DS, Machulda M, Lowe VJ, Mielke MM, Roberts RO, Gunter JL, Senjem ML, Geda YE, Rocca WA, Petersen RC, Jack CR Jr.

Neurology. 2016 Mar 22;86(12):1128-35. doi: 10.1212/WNL.0000000000002490. Epub 2016 Feb 24.

50.

Atrial fibrillation, cognitive impairment, and neuroimaging.

Graff-Radford J, Madhavan M, Vemuri P, Rabinstein AA, Cha RH, Mielke MM, Kantarci K, Lowe V, Senjem ML, Gunter JL, Knopman DS, Petersen RC, Jack CR Jr, Roberts RO.

Alzheimers Dement. 2016 Apr;12(4):391-8. doi: 10.1016/j.jalz.2015.08.164. Epub 2015 Oct 23.

Supplemental Content

Loading ...
Support Center